COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Diagnosis and Management in Dementia - 1st Edition - ISBN: 9780128158548, 9780128158555

Diagnosis and Management in Dementia

1st Edition

The Neuroscience of Dementia, Volume 1

Editors: Colin Martin Victor Preedy
Hardcover ISBN: 9780128158548
eBook ISBN: 9780128158555
Imprint: Academic Press
Published Date: 18th September 2020
Page Count: 910
Sales tax will be calculated at check-out Price includes VAT/GST
175.00
155.00
200.00
320.91
Unavailable
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

Diagnosis and Management in Dementia: The Neuroscience of Dementia, Volume 1 consolidates different fields of dementia into a single book, covering a range of subjects, including Alzheimer’s disease, Lewy body dementia, mixed dementia, vascular dementia, physical activity, risk factors, mortality, biomarkers, SPECT, CT, MRI, questionnaires, nutrition, sleep, delirium, hearing loss, agitation, aggression, delusions, anxiety, depression, hallucinations, psychosis, senile plaques, tau and amyloid-beta, neuroinflammation, molecular biology, and more. With an impact on millions globally, and billions of research dollars being invested in dementia research, this book will stimulate research in the area and inform researchers.

Key Features

  • Offers comprehensive coverage of a broad range of topics related to dementia
  • Serves as a foundational collection for neuroscientists and neurologists on the biology of dementia and brain dysfunction
  • Contains in each chapter an abstract, key facts, mini dictionary of terms, and summary points to aid in understanding
  • Provides unique sections on specific subareas, intellectual components, and knowledge-based niches that will help readers navigate key areas for research and further clinical recommendations
  • Features preclinical and clinical studies to help researchers map out key areas for research and further clinical recommendations
  • Serves as a "one-stop" source for everything you need to know about dementia

Readership

Neuroscientists/neurologists, psychologists, health scientists, public health workers, research scientists, pharmacologists, and physicians. Graduate/postgraduate students, lecturers, and professors

Table of Contents

Part I: Dementia: introductory chapters and setting the scene

1. Mixed dementia: a neuropathological overview
Jacques De Reuck

2. Vascular dementia: an overview
Virginia Cipollini, Fernanda Troili and Franco Giubilei

3. Small vessel disease and dementia
Francesco Arba and Valentina Rinnoci

4. Linking amyotrophic lateral sclerosis and frontotemporal dementia
Couratier Philippe

5. Mortality in dementia: linking in the role of delirium
Flavia Barreto Garcez and Thiago Junqueira Avelino-Silva

6. Midlife diabetes and the risk of dementia: understanding the link
Adam H. Dyer and Sean P. Kennelly

7. Gait and dementia
Oshadi Jayakody and Michele L. Callisaya

8. The role of blood pressure and hypertension in dementia
Keenan A. Walker and Rebecca F. Gottesman

9. Genetics of dementia: a focus on Alzheimer’s disease
Francesca Fernandez and Jessica L. Andrews

10. Clinical and pathological phenotypes in dementia: a focus on autosomal dominant frontotemporal dementia
Innocenzo Rainero, Alessandro Vacca and Elisa Rubino

11. Environmental and genetic risk factors for dementia
Vanesa Bellou, Lazaros Belbasis and Evangelos Evangelou

12. Lipids, brain ageing, dementia, and lipidomics
Anne Poljak, Braidy Nady, Wong Matthew Wai Kin, Yue Liu, Mahboobeh Housseini and Sachdev Perminder Singh

13. The 5xFAD mouse model of Alzheimer’s disease
Caroline Ismeurt, Patrizia Giannoni and Sylvie Claeysen

Part II: Biomarkers, psychometric instruments and diagnosis

14. Use of cerebrospinal fluid in diagnosis of dementia
Angelo Nuti, Cecilia Carlesi, Elena Caldarazzo Ienco, Gabriele Cipriani and Paolo Del Dotto

15. Salivary biomarkers in Alzheimer’s disease
Jessica L. Andrews and Francesca Fernandez

16. Diacylglycerols: biomarkers of a sustained immune response in proteinopathies
Paul L. Wood and Randall J. Woltjer

17. Butyrylcholinesterase as a biomarker in Alzheimer’s disease
Drew R. DeBay and Sultan Darvesh

18. Blood brain-derived neurotrophic factor as a biomarker of Alzheimer’s disease
Marta Balietti

19. The neuroscience of dementia: diagnosis and management methods of amyloid positron emission tomography imaging and its application to the Alzheimer’s disease spectrum
Shizuo Hatashita

20. Diffusion-weighted imaging (DWI) tractography and Alzheimer’s disease
Nicola Amoroso

21. Transcranial magnetic stimulation in the cortical exploration of dementia
Thanuja Dharmadasa, William Huynh and Matthew C. Kiernan

22. The role of retinal imaging in Alzheimer’s disease
Victor T.T. Chan and Carol Y. Cheung

23. Prediction of Alzheimer’s disease
Athanasios Alexiou, Stylianos Chatzichronis and Ghulam Md Ashraf

24. Addenbrooke’s Cognitive Examination
Jordi A. Matias-Guiu

 25. Beyond the cutoffs: a Bayesian approach to the use of the Montreal Cognitive Assessment as a screening tool for mild cognitive impairment and dementia
Andrea Bosco, Alessandro O. Caffo, Giuseppina Spano and Antonella Lopez

26. Utility of ALBA screening instrument: the prodromal phase of dementia with Lewy bodies
Waleska Berríos and Angel Golimstok

27. The quick mild cognitive impairment screen and applications to dementia
Ron an O’Caoimh, D. William Molloy and Roger Clarnette

28. The usefulness of evaluating performance of activities of daily living in the diagnosis of mild cognitive disorders
Patricia De Vriendt, Elise Cornelis and Ellen Gorus

Part III: Pharmacological treatments for dementia

29. Cholinesterase inhibitors in dementias: an overview
Patrizia Mecocci, Lucia Paolacci and Virginia Boccardi

30. Choline-containing phospholipids and treatment of adult-onset dementia disorders
Francesco Amenta, Gopi Battineni, Enea Traini and Graziano Pallotta

31. Donepezil in the treatment of Alzheimer’s disease
Gabriella Marucci, Michele Moruzzi and Francesco Amenta

32. Memantine and Alzheimer’s disease: a comprehensive review
Sergio del Río-Sancho

33. A new neuroprotective strategy for the drug therapy of Parkinson’s disease: the Ca2þ/cAMP signaling as therapeutic target
Afonso Caricati-Neto, Fulvio Alexandre Scorza and Leandro Bueno Bergantin

34. Pitfalls and possible solutions for research and development of dementia therapies
Thomas Muller €

35. All-trans retinoic acid in Alzheimer’s disease
Siamak Beheshti

36. Dementia and usage of N-methyl-D-aspartate receptor antagonists
B.E. Glynn-Servedio

37. Swallowing impairment in Parkinson’s disease
Maira Rozenfeld Olchik, Marina Padovani and Annelise Ayres

38. Linking astrocytes’ exosomes to Alzheimer pathogenesis and therapy
Anna M. Chiarini, Ubaldo Armato, Claudio Eccher and Ilaria Dal Pr

39. Changing fate: therapeutic mechanisms focused on the switch of amyloid precursor protein processing
Sven Reinhardt and Kristina Endres

40. Acetylcholinesterase inhibitory agents in plants and their application to dementia: Alzheimer’s disease
Willian Orlando Castillo-Ordonez and Nohelia Cajas-Salazar

41. Removal of blood amyloid-b as an effective and safe therapeutic strategy
Nobuya Kitaguchi, Kazunori Kawaguchi and Kazuyoshi Sakai

Part IV: Non-pharmacological treatments and procedures

42. Caring for people with dementia in the acute hospital
Robert Briggs, Paul Claffey and Sean P. Kennelly

43. Environmental enrichment as a preventative and therapeutic approach to Alzheimer’s disease
Kimberley E. Stuart, Anna E. King and James C. Vickers

44. Music therapy in dementia: the effects of music therapy and other musical interventions on behavior, emotion, and cognition
Alfredo Raglio and Lapo Attardo

45. Exploitation of aromatherapy in dementiadimpact on pain and neuropsychiatric symptoms
Damiana Scuteri, Laura Rombol

46. Dancing in dementia
Lee-Fay Low, Helen Parker, Kathryn Dovey and Alycia Fong Yan

47. Hypoxicehyperoxic conditioning and dementia
Robert T. Mallet, Johannes Burtscher, Eugenia B. Manukhina, H. Fred Downey, Oleg S. Glazachev, Tatiana V. Serebrovskaya and Martin Burtscher

48. Linking amyloid and depression in the development of Alzheimer’s disease: effects of neuromodulatory interventions by brain stimulation
Akihiko Nunomura, Toshio Tamaoki, Kenji Tagai, Shinsuke Kito, Shunichiro Shinagawa and Masahiro Shigeta

49. Regional and local dementia care networks
Franziska Laporte Uribe, Karin Wolf-Ostermann, Jochen Rene Thyrian and Bernhard Holle

50. Cognitive behavioral therapy use in Alzheimer’s disease: mitigating risks associated with the olfactory brain
Larry D. Reid, Dylan Z. Taylor and Alicia A. Walf

51. Maximizing cognition in mild cognitive impairment and early stage dementia
Bridget Regan, Yvonne Wells and Paul O’Halloran

52. Exercise, cognitive creativity, and dementia
Emily Frith and Paul D. Loprinzi

53. Person-centered communication among formal caregivers of persons with dementia
Marie Y. Savundranayagam and Pabiththa Kamalraj

Index

Details

No. of pages:
910
Language:
English
Copyright:
© Academic Press 2020
Published:
18th September 2020
Imprint:
Academic Press
Hardcover ISBN:
9780128158548
eBook ISBN:
9780128158555

About the Editors

Colin Martin

Dr. Martin is a Professor of Mental Health at Buckinghamshire New University. He is a Registered Nurse, Chartered Health Psychologist, and a Chartered Scientist. He has published or has in press well over 250 research papers and book chapters. He is a keen book author and editor having written and/or edited several books all of which reflect his diverse academic and clinical interests that examine in-depth, the interface between mental health and physical health. These outputs include the Handbook of Behavior; Food and Nutrition (2011), Perinatal Mental Health: A Clinical Guide (2012); Nanomedicine and the Nervous System (2012), and the major reference works Comprehensive Guide to Autism (2014), Diet and Nutrition in Dementia and Cognitive Decline (2015), Comprehensive Guide to Post-Traumatic Stress Disorder (2016) and Metabolism and Pathophysiology of Bariatric Surgery: Nutrition, Procedures, Outcomes, and Adverse Effects (2017).

Affiliations and Expertise

Professor of Mental Health, Bickinghamshire New University, High Wycombe, Buckinghamshire, England, United Kingdom

Victor Preedy

Dr. Preedy is a senior member of King's College London and Director of the Genomics Centre and a member of the Faculty of Life Sciences and Medicine. Professor Preedy has longstanding academic interests in substance misuse especially in relation to health and well-being. In his career Professor Preedy was Reader at the Addictive Behaviour Centre at The University of Roehampton, and also Reader at the School of Pharmacy (now part of University College London; UCL). Professor Preedy is an extremely experienced book editor, having edited influential works including but not limited to The Handbook of Alcohol Related Pathology, The Neuropathology of Drug Addictions and Substance Misuse, The Handbook of Cannabis and Related Pathologies, The Neuroscience of Cocaine, and upcoming titles The Neuroscience of Alcohol, The Neuroscience of Nicotine, and more (all Elsevier).

Affiliations and Expertise

Professor of Nutritional Biochemistry, Department of Nutrition and Dietetics, Professor of Clinical Biochemistry, Department of Clinical Biochemistry; Director of the Genomics Centre, King’s College, London, UK

Ratings and Reviews